| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 04.03.2015 og
angivet som gældende fra 04.02.1971 (19448
dage). |
Ingen historik.
| Branche | | Engroshandel med læge- og hospitalsartikler (464620). |
| Sidst opdateret den 25.12.2007 og
angivet som gældende fra 01.01.2008 (5968
dage). |
| Historik | Start | Stop |
|---|
| Engroshandel med læge- og hospitalsartikler (464620) | 01.01.2008 | |
| Engroshandel med læge- og hospitalsartikler (514620) | 04.02.1971 | 31.12.2007 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 04.02.1971 (19448
dage). |
Ingen historik.
| Historik | Start | Stop |
|---|
| birgitte.engelsen@abbot.com | 20.10.2003 | 09.12.2004 |
| Virksomheden har ikke ændret Kontakt i sin
levetid. |
Ingen nuværende registrering.
| Telefonnummer | | 39770000. |
| Sidst opdateret den 28.11.2012 og
angivet som gældende fra 20.10.2003 (7502
dage). |
Ingen historik.
| Navne | | ABBOTT LABORATORIES A/S. |
| Sidst opdateret den 22.11.2013 og
angivet som gældende fra 04.02.1971 (19448
dage). |
Ingen historik.
| Binavne | | ABBOTT PRODUCTS A/S. |
| Sidst opdateret den 04.03.2015 og
angivet som gældende fra 04.02.1971 (19448
dage). |
| Historik | Start | Stop |
|---|
| ABBOTT PRODUCTS A/S | 04.02.1971 | |
| MEDISENSE A/S | 04.02.1971 | |
| REAMED A/S | 04.02.1971 | 17.07.2009 |
| Tegningsregel | | Selskabet tegnes af en direktør og et medlem af bestyrelsen i fælleskab eller af den samlede bestyrelse. |
| Sidst opdateret den 04.03.2015 og
angivet som gældende fra 21.12.2012 (4152
dage). |
| Fortolkning
(2 tegningsmuligheder)
| | 1 direktør og 1 bestyrelsesmedlem i fælleskab |
| bestyrelsen |
Ingen historik.
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:EY Godkendt Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:30700228
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Regnskabsklasse C, mellemstor virksomhed
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code) and additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these rules and requirements and the IESBA Code.
Konklusion (revision):We have audited the financial statements of Abbott Laboratories A/S for the financial year 1 January – 31 December 2022, which comprise income statement, balance sheet, statement of changes in equity, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2022 and of the results of the Company's operations for the financial year 1 January – 31 December 2022 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration